AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% Drug Patent Profile
✉ Email this page to a colleague
When do Aminophylline In Sodium Chloride 0.45% patents expire, and when can generic versions of Aminophylline In Sodium Chloride 0.45% launch?
Aminophylline In Sodium Chloride 0.45% is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% is aminophylline. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aminophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminophylline In Sodium Chloride 0.45%
A generic version of AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% was approved as aminophylline by HOSPIRA on October 26th, 1983.
Summary for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 36 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% at DailyMed |
Recent Clinical Trials for AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical College of Wisconsin | Phase 1/Phase 2 |
University of Oklahoma | Phase 1/Phase 2 |
Institute of Liver and Biliary Sciences, India | N/A |
See all AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% clinical trials